Table 2 Baseline characteristics and univariate analyses of prognostic factors of 69 patients with NPC.
Characteristic | MMR status n (%) | χ2 | P value | OS | PFS | LRFS | DMFS | |
|---|---|---|---|---|---|---|---|---|
pMMR | dMMR | P | P | P | P | |||
Sex | 1.16 | 0.28 | 0.39 | 0.85 | 0.77 | 0.67 | ||
Male | 25 (71.4) | 28 (82.4) | ||||||
Female | 10 (28.6) | 6 (17.6) | ||||||
Age (years) | 2.44 | 0.12 | 0.07 | 0.02 | 0.04 | 0.04 | ||
<53 | 13 (37.1) | 19 (55.9) | ||||||
≥53 | 22 (62.9) | 15 (44.1) | ||||||
Histological pathology typea | NA | NA | NA | NA | NA | NA | ||
Type 1 | 0 (0.0) | 0 (0.0) | ||||||
Type 2 | 35 (100.0) | 34 (100.0) | ||||||
Type 3 | 0 (0.0) | 0 (0.0) | ||||||
Clinical stageb | 0.17 | 1.00 | 0.01 | 0.05 | 0.50 | 0.08 | ||
II | 5 (14.3) | 4 (11.8) | ||||||
III | 16 (45.7) | 16 (47.1) | ||||||
IVa | 14 (40.0) | 14 (41.2) | ||||||
T-categoryb | 0.01 | 0.95 | 0.02 | 0.03 | 0.08 | 0.04 | ||
T1-2 | 8 (22.9) | 8 (23.5) | ||||||
T3-4 | 27 (77.1) | 26 (76.5) | ||||||
N-categoryb | 0.13 | 0.71 | 0.06 | 0.23 | 0.21 | 0.50 | ||
N0-2 | 29 (82.9) | 27 (79.4) | ||||||
N3 | 6 (17.1) | 7 (20.6) | ||||||
Therapy regimens | 0.17 | 0.92 | 0.11 | 0.18 | 0.45 | 0.24 | ||
IMRT | 8 (22.9) | 9 (26.5) | ||||||
CCRT | 17 (48.6) | 15 (44.1) | ||||||
ACCRT | 10 (28.6) | 10 (29.4) | ||||||
MMR status | NA | NA | 0.06 | 0.09 | 0.95 | 0.02 | ||
pMMR | NA | NA | ||||||
dMMR | NA | NA | ||||||
